{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:58:07Z","timestamp":1791979087519,"version":"4.4.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"DOI":"10.1093\/jac\/dku379","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T02:50:28Z","timestamp":1412045428000},"page":"382-395","source":"Crossref","is-referenced-by-count":187,"title":["Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis"],"prefix":"10.1093","volume":"70","author":[{"given":"Johannes","family":"Nemeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Oesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan P.","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,9,28]]},"reference":[{"key":"key\n\t\t\t\t20170425183710_DKU379C1","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","article-title":"Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer","volume":"30","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170425183710_DKU379C2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170425183710_DKU379C3","volume-title":"Infectious Diseases, 2 vols","year":"2003"},{"key":"key\n\t\t\t\t20170425183710_DKU379C4","volume-title":"Harrison's Principles of Internal Medicine","year":"2008"},{"key":"key\n\t\t\t\t20170425183710_DKU379C5","author":"Cubist Pharmaceuticals Inc"},{"key":"key\n\t\t\t\t20170425183710_DKU379C6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjsurg.2009.08.045","article-title":"Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus","volume":"199","year":"2010","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t20170425183710_DKU379C8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/497271","article-title":"Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jac\/dkm369","article-title":"Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan","volume":"60","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijantimicag.2008.04.004","article-title":"Linezolid for the treatment of infections caused by Gram-positive pathogens in China","volume":"32","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425183710_DKU379C11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/0036554021000026933","article-title":"Linezolid versus ceftriaxone\/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia","volume":"34","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C12","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.7326\/0003-4819-124-8-199604150-00003","article-title":"Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis","volume":"124","year":"1996","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170425183710_DKU379C14","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Cochrane Collaboration"},{"key":"key\n\t\t\t\t20170425183710_DKU379C15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diagmicrobio.2008.09.001","article-title":"Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin","volume":"63","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02310353","article-title":"Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia","volume":"14","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425183710_DKU379C17","first-page":"28","article-title":"Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience","volume":"20","year":"2008","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF01700406","article-title":"Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia","volume":"16","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1179\/joc.2005.17.6.636","article-title":"Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study","volume":"17","year":"2005","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jac\/9.6.479","article-title":"A comparison of cefuroxime and co-trimoxazole in severe respiratory tract infections","volume":"9","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2710.2009.01073.x","article-title":"Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia","volume":"35","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t20170425183710_DKU379C22","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/AAC.44.7.1796-1802.2000","article-title":"Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group","volume":"44","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/14.1.75","article-title":"Erythromycin compared with a combination of ampicillin plus flucloxacillin for the treatment of community acquired pneumonia in adults","volume":"14","year":"1984","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 43","key":"key\n\t\t\t\t20170425183710_DKU379C24","first-page":"53","article-title":"A comparative trial of cephaloridine and erythromycin in hospitalized pneumonic patients","volume":"43","year":"1967","journal-title":"Postgrad Med J"},{"key":"key\n\t\t\t\t20170425183710_DKU379C25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2008.04.009","article-title":"Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia","volume":"61","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2466-9-44","article-title":"Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia","volume":"9","year":"2009","journal-title":"BMC Pulm Med"},{"key":"key\n\t\t\t\t20170425183710_DKU379C27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.1992.tb08048.x","article-title":"Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study","volume":"127","year":"1992","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t20170425183710_DKU379C28","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/AAC.49.11.4658-4666.2005","article-title":"Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jmii.2010.04.002","article-title":"Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan","volume":"44","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170425183710_DKU379C30","first-page":"S341","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijid.2005.05.003","article-title":"Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized, double-blind trial","volume":"9","year":"2005","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C32","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2334-10-217","article-title":"Efficacy and safety of tigecycline monotherapy vs. imipenem\/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial","volume":"10","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2334-5-88","article-title":"A multicenter trial of the efficacy and safety of tigecycline versus imipenem\/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]","volume":"5","year":"2005","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/sur.2011.048","article-title":"Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial","volume":"13","year":"2012","journal-title":"Surg Infect"},{"key":"key\n\t\t\t\t20170425183710_DKU379C36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1469-0691.2010.03122.x","article-title":"A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections","volume":"16","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170425183710_DKU379C37","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/317450","article-title":"Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children","volume":"31","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jac\/dkm369","article-title":"Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan","volume":"60","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","year":"1992","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170425183710_DKU379C40","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1086\/500137","article-title":"Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania","volume":"42","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C41","first-page":"337","article-title":"Intravenous mecillinam, trimethoprim and ampicillin in acute pyelonephritis","volume":"9","year":"1983","journal-title":"Drugs Exp Clin Res"},{"key":"key\n\t\t\t\t20170425183710_DKU379C42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s100960050258","article-title":"Prospective, randomized dose-ranging open phase II pilot study of quinupristin\/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia","volume":"18","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","article-title":"Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis","volume":"11","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C44","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.01232-12","article-title":"Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C45","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/AAC.01009-12","article-title":"Breakthrough bacteremia due to extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae during combination therapy with colistin and tigecycline","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183710_DKU379C46","volume-title":"Principles and Practice of Infectious Diseases","year":"2010"},{"key":"key\n\t\t\t\t20170425183710_DKU379C47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/500139","article-title":"Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer","volume":"42","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C48","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections","volume":"38","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C49","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/cid\/cis473","article-title":"Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183710_DKU379C50","article-title":"Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model","year":"2014","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T16:22:59Z","timestamp":1565886179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dku379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,28]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,9,28]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku379","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,28]]}}}